As the financial markets opened on August 20, 2024, investors were keeping a close eye on three major stocks: Eli Lilly and Company (NYSE: LLY), Tesla (NASDAQ: TSLA), and Bank of America Corporation (NYSE: BAC). Each of these companies has recently made significant announcements that are expected to impact their stock performance and influence broader market trends.
Eli Lilly (LLY) Shares Surge on Tirzepatide Breakthrough
Eli Lilly’s stock price soared by 4.66% to $964.82 in early trading following groundbreaking news about its drug tirzepatide. The company revealed that its 176-week SURMOUNT-1 Phase 3 study had shown tirzepatide to reduce the risk of developing type 2 diabetes by an impressive 94% in adults with pre-diabetes and obesity or overweight.
The study, which involved 1,032 adults, also demonstrated sustained weight loss, with the 15 mg dose resulting in an average decrease of 22.9% in body weight by the end of the treatment period.
Tirzepatide, marketed as Mounjaro for type 2 diabetes and Zepbound for weight management, functions by activating hormone receptors that regulate appetite and caloric intake. This latest data further solidifies the drug’s potential as a long-term therapy for obesity and pre-diabetes.
Eli Lilly’s stock has shown remarkable performance, with a year-to-date return of 65.96% and a five-year return of 816.55%, reflecting strong investor confidence in the company’s innovative pipeline.
Tesla (TSLA) Stock Receives Boost from Reduced EU Tariffs
Tesla’s stock experienced a slight increase of 0.13% to $223.01 in morning trading, driven by news of reduced tariffs on its China-made vehicles exported to the European Union. The EU has lowered the planned tariff on Tesla’s Chinese-built cars to 9%, down from the previously indicated 20.8% in July. This decision is part of the EU’s investigation into alleged Chinese subsidies for electric vehicle manufacturers.
The reduced tariff could have a significant impact on Tesla’s competitiveness in the European market, potentially enabling the company to price its China-made vehicles more aggressively.
Despite facing challenges earlier this year, with a year-to-date return of -10.23%, Tesla continues to exhibit strong long-term performance, boasting a five-year return of 1,375.00%.
Bank of America (BAC) Stock Declines as Berkshire Trims Stake
Bank of America’s stock dropped by 2.48% to $38.69 in early trading following reports that Warren Buffett’s Berkshire Hathaway (NYSE: BRK.A) had sold over $550 million worth of BAC shares. These sales, which occurred on August 15, 16, and 19, reduced Berkshire’s stake in the bank to approximately 12%. The shares were sold at prices ranging from $39.2719 to $39.6454 per share.
Buffett’s decision to reduce his stake in Bank of America, known for his long-term investment approach, has garnered attention from market observers. It appears to be part of a broader trend of Buffett trimming positions in some of his long-standing investments.
Despite this development, Bank of America’s stock has demonstrated resilience, with a year-to-date return of 16.41% and a one-year return of 36.85%. The bank’s current market capitalization stands at $300.179 billion, with a price-to-earnings ratio of 13.92.
***
Disclaimer: The information provided in this article is for informational purposes only and should not be construed as financial advice. It is recommended to consult with a financial advisor before making any investment decisions.
This article was originally published on The Tokenist. Subscribe to The Tokenist’s free newsletter, Five Minute Finance, for weekly insights into the latest trends in finance and technology.